Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy.
Madeddu C, Deidda M, Piras A, Cadeddu C, Demurtas L, Puzzoni M, Piscopo G, Scartozzi M, Mercuro G. Madeddu C, et al. Among authors: puzzoni m. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S12-8. doi: 10.2459/JCM.0000000000000376. J Cardiovasc Med (Hagerstown). 2016. PMID: 27183520 Review.
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?
Puzzoni M, Silvestris N, Leone F, Giampieri R, Faloppi L, Demurtas L, Dell'Aquila E, Marino D, Brunetti O, Garattini SK, Ongaro E, Astara G, Orgiano L, Aprile G, Santini D, Scartozzi M. Puzzoni M, et al. Target Oncol. 2016 Oct;11(5):593-603. doi: 10.1007/s11523-016-0437-6. Target Oncol. 2016. PMID: 27184491 Review.
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy.
Madeddu C, Deidda M, Piras A, Cadeddu C, Demurtas L, Puzzoni M, Piscopo G, Scartozzi M, Mercuro G. Madeddu C, et al. Among authors: puzzoni m. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection:e12-e18. doi: 10.2459/JCM.0000000000000376. J Cardiovasc Med (Hagerstown). 2016. PMID: 27755238 Review.
[Cancer cachexia assessment: new tools for oncologists.].
Serpe R, Demurtas L, Puzzoni M, Madeddu C, Scartozzi M. Serpe R, et al. Among authors: puzzoni m. Recenti Prog Med. 2016 Oct;107(10):515-524. doi: 10.1701/2454.25702. Recenti Prog Med. 2016. PMID: 27782227 Review. Italian.
Immunotherapy for colorectal cancer: where are we heading?
Basile D, Garattini SK, Bonotto M, Ongaro E, Casagrande M, Cattaneo M, Fanotto V, De Carlo E, Loupakis F, Urbano F, Negri FV, Pella N, Russano M, Brunetti O, Scartozzi M, Santini D, Silvestris N, Casadei Gardini A, Puzzoni M, Calvetti L, Cardarelli N, Aprile G. Basile D, et al. Among authors: puzzoni m. Expert Opin Biol Ther. 2017 Jun;17(6):709-721. doi: 10.1080/14712598.2017.1315405. Epub 2017 Apr 13. Expert Opin Biol Ther. 2017. PMID: 28375039 Free article. Review.
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis.
Giampieri R, Prete MD, Prochilo T, Puzzoni M, Pusceddu V, Pani F, Maccaroni E, Mascia R, Baleani MG, Meletani T, Berardi R, Lanzillo AM, Mariotti S, Zaniboni A, Cascinu S, Scartozzi M. Giampieri R, et al. Among authors: puzzoni m. Sci Rep. 2017 Apr 5;7:45703. doi: 10.1038/srep45703. Sci Rep. 2017. PMID: 28378839 Free PMC article.
56 results